Vanguard Group Inc. boosted its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 8.2% during the first quarter, Holdings Channel reports. The fund owned 1,729,406 shares of the company’s stock after buying an additional 130,935 shares during the period. Vanguard Group Inc.’s holdings in Phibro Animal Health Corporation were worth $48,597,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of PAHC. Chicago Equity Partners LLC purchased a new stake in Phibro Animal Health Corporation during the first quarter valued at about $376,000. Great West Life Assurance Co. Can raised its stake in Phibro Animal Health Corporation by 7.3% in the first quarter. Great West Life Assurance Co. Can now owns 26,554 shares of the company’s stock valued at $745,000 after buying an additional 1,802 shares during the last quarter. Wells Fargo & Company MN raised its stake in Phibro Animal Health Corporation by 0.7% in the first quarter. Wells Fargo & Company MN now owns 125,941 shares of the company’s stock valued at $3,540,000 after buying an additional 932 shares during the last quarter. Russell Investments Group Ltd. purchased a new stake in Phibro Animal Health Corporation during the first quarter valued at about $748,000. Finally, Sit Investment Associates Inc. purchased a new stake in Phibro Animal Health Corporation during the first quarter valued at about $2,037,000. 47.41% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.25% during midday trading on Friday, hitting $39.40. 5,850 shares of the stock traded hands. The company’s 50 day moving average is $37.96 and its 200-day moving average is $32.15. Phibro Animal Health Corporation has a one year low of $20.14 and a one year high of $39.95. The company has a market cap of $1.56 billion, a P/E ratio of 24.47 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its earnings results on Monday, May 8th. The company reported $0.37 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.37. The business had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 earnings per share. On average, equities research analysts forecast that Phibro Animal Health Corporation will post $1.45 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.02%. The ex-dividend date is Friday, September 1st. Phibro Animal Health Corporation’s payout ratio is 24.69%.

COPYRIGHT VIOLATION WARNING: This news story was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/08/11/phibro-animal-health-corporation-pahc-stake-increased-by-vanguard-group-inc.html.

Several equities research analysts have recently issued reports on the stock. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and increased their target price for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Finally, Zacks Investment Research raised shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research note on Thursday, May 11th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $30.50.

In other news, insider Jack Bendheim sold 48,000 shares of Phibro Animal Health Corporation stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $34.15, for a total value of $1,639,200.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, major shareholder Bfi Co., Llc sold 16,000 shares of Phibro Animal Health Corporation stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $36.00, for a total transaction of $576,000.00. Following the completion of the sale, the insider now directly owns 28,000 shares in the company, valued at approximately $1,008,000. The disclosure for this sale can be found here. In the last ninety days, insiders sold 352,000 shares of company stock worth $12,599,200. Insiders own 48.09% of the company’s stock.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.